Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Avycaz demonstrates efficacy in phase III trial in cUTI

Sep. 3, 2015

Janssen introduces anti-HBV agents

Sep. 3, 2015

Daktari Diagnostics and Merck & Co. to collaborate on point-of-care HCV test

Sep. 3, 2015

Ring vaccination trial of Ebola virus vaccine VSV-EBOV extended to Sierra Leone

Sep. 2, 2015

Encouraging results reported for Vaxart's oral influenza vaccine

Sep. 2, 2015

MicuRx's MRX-I shows comparable clinical cure rate to linezolid in phase II trial

Sep. 2, 2015

Gilead launches Harvoni in Japan for the treatment of genotype 1 chronic HCV infection

Aug. 31, 2015

Fixed Phage reports bacteriophage-based antibacterials

Aug. 31, 2015

Enrollment complete in second pivotal trial of Symbiomix Therapeutics' SYM-1219

Aug. 28, 2015

Opal Biosciences updates on development of antimicrobial platform

Aug. 28, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...